Skip to main content

Thepaut Eric Francis Yves's Form 4 filing

Boston Scientific Corp (BSX) · filed May 13, 2024

Accession no.
0001225208-24-005975
Filed
May 13, 2024
Trade date
May 10, 2024
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $958.7K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Thepaut Eric Francis YvesCIK 0001631992Officer (EVP & Pres, Eur, Mid-East, Afr)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 10, 2024Common StockMOption exerciseAcquired+12,931$16.31+$210,904.6144,352.99Direct
May 10, 2024Common StockSSaleDisposed−12,931$74.14F1−$958,704.3431,421.99Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 10, 2024Common StockMOption exerciseDisposed−12,931$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.165, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)